ScholarLens Back to search
2000•Clinical Infectious DiseasesOpen access

Empirical Antimicrobial Therapy for Traveler's Diarrhea

Javier A. Adachi, Luis Ostrosky‐Zeichner, Herbert L. DuPont, Charles D. Ericsson, Charles D. Ericsson

Open full text 86 citations

Abstract

Over 7 million cases of traveler's diarrhea, defined as the passage of > or = 3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominantly caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler's diarrhea.

Open-access reader

About this research paper

What this paper is about

Over 7 million cases of traveler's diarrhea, defined as the passage of > or = 3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominantly caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler's diarrhea.

Why it matters

OpenAlex reports 86 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Over 7 million cases of traveler's diarrhea, defined as the passage of > or = 3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominantly caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler's diarrhea.

Key concepts: Traveler's diarrhea, Diarrhea, Medicine, Azithromycin, Campylobacter, Antimicrobial, Empirical treatment, Intensive care medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Empirical Antimicrobial Therapy for Traveler's Diarrhea — Research Paper | ScholarLens